185 related articles for article (PubMed ID: 28498651)
1. Design of Benzoxathiazin-3-one 1,1-Dioxides as a New Class of Irreversible Serine Hydrolase Inhibitors: Discovery of a Uniquely Selective PNPLA4 Inhibitor.
Kornahrens AF; Cognetta AB; Brody DM; Matthews ML; Cravatt BF; Boger DL
J Am Chem Soc; 2017 May; 139(20):7052-7061. PubMed ID: 28498651
[TBL] [Abstract][Full Text] [Related]
2. Discovery libraries targeting the major enzyme classes: the serine hydrolases.
Otrubova K; Srinivasan V; Boger DL
Bioorg Med Chem Lett; 2014 Aug; 24(16):3807-13. PubMed ID: 25037918
[TBL] [Abstract][Full Text] [Related]
3. Proteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibition.
Chang JW; Cognetta AB; Niphakis MJ; Cravatt BF
ACS Chem Biol; 2013 Jul; 8(7):1590-9. PubMed ID: 23701408
[TBL] [Abstract][Full Text] [Related]
4. Competitive activity-based protein profiling identifies aza-β-lactams as a versatile chemotype for serine hydrolase inhibition.
Zuhl AM; Mohr JT; Bachovchin DA; Niessen S; Hsu KL; Berlin JM; Dochnahl M; López-Alberca MP; Fu GC; Cravatt BF
J Am Chem Soc; 2012 Mar; 134(11):5068-71. PubMed ID: 22400490
[TBL] [Abstract][Full Text] [Related]
5. Selective N-Hydroxyhydantoin Carbamate Inhibitors of Mammalian Serine Hydrolases.
Cognetta AB; Niphakis MJ; Lee HC; Martini ML; Hulce JJ; Cravatt BF
Chem Biol; 2015 Jul; 22(7):928-37. PubMed ID: 26120000
[TBL] [Abstract][Full Text] [Related]
6. Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors.
Adibekian A; Martin BR; Wang C; Hsu KL; Bachovchin DA; Niessen S; Hoover H; Cravatt BF
Nat Chem Biol; 2011 May; 7(7):469-78. PubMed ID: 21572424
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and in vitro evaluation of inhibitors of human leukocyte elastase based on a functionalized cyclic sulfamide scaffold.
Zhong J; Gan X; Alliston KR; Groutas WC
Bioorg Med Chem; 2004 Feb; 12(3):589-93. PubMed ID: 14738969
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors.
Glunz PW; Cheng X; Cheney DL; Weigelt CA; Wei A; Luettgen JM; Wong PC; Wexler RR; Priestley ES
Bioorg Med Chem Lett; 2015; 25(10):2169-73. PubMed ID: 25881820
[TBL] [Abstract][Full Text] [Related]
9. Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP).
Haffner CD; Diaz CJ; Miller AB; Reid RA; Madauss KP; Hassell A; Hanlon MH; Porter DJ; Becherer JD; Carter LH
Bioorg Med Chem Lett; 2008 Aug; 18(15):4360-3. PubMed ID: 18606544
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold.
Groutas WC; Kuang R; Venkataraman R; Epp JB; Ruan S; Prakash O
Biochemistry; 1997 Apr; 36(16):4739-50. PubMed ID: 9125494
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of a new class of 1-oxacephem-based human chymase inhibitors.
Aoyama Y; Uenaka M; Konoike T; Iso Y; Nishitani Y; Kanda A; Naya N; Nakajima M
Bioorg Med Chem Lett; 2000 Nov; 10(21):2397-401. PubMed ID: 11078187
[TBL] [Abstract][Full Text] [Related]
12. Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors.
Lawandi J; Toumieux S; Seyer V; Campbell P; Thielges S; Juillerat-Jeanneret L; Moitessier N
J Med Chem; 2009 Nov; 52(21):6672-84. PubMed ID: 19888757
[TBL] [Abstract][Full Text] [Related]
13. Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets.
Katz BA; Sprengeler PA; Luong C; Verner E; Elrod K; Kirtley M; Janc J; Spencer JR; Breitenbucher JG; Hui H; McGee D; Allen D; Martelli A; Mackman RL
Chem Biol; 2001 Nov; 8(11):1107-21. PubMed ID: 11731301
[TBL] [Abstract][Full Text] [Related]
14. General and Modular Strategy for Designing Potent, Selective, and Pharmacologically Compliant Inhibitors of Rhomboid Proteases.
Tichá A; Stanchev S; Vinothkumar KR; Mikles DC; Pachl P; Began J; Škerle J; Švehlová K; Nguyen MTN; Verhelst SHL; Johnson DC; Bachovchin DA; Lepšík M; Majer P; Strisovsky K
Cell Chem Biol; 2017 Dec; 24(12):1523-1536.e4. PubMed ID: 29107700
[TBL] [Abstract][Full Text] [Related]
15. Chemoproteomic, biochemical and pharmacological approaches in the discovery of inhibitors targeting human α/β-hydrolase domain containing 11 (ABHD11).
Navia-Paldanius D; Patel JZ; López Navarro M; Jakupović H; Goffart S; Pasonen-Seppänen S; Nevalainen TJ; Jääskeläinen T; Laitinen T; Laitinen JT; Savinainen JR
Eur J Pharm Sci; 2016 Oct; 93():253-63. PubMed ID: 27544863
[TBL] [Abstract][Full Text] [Related]
16. Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease.
Dhanak D; Burton G; Christmann LT; Darcy MG; Elrod KC; Kaura A; Keenan RM; Link JO; Peishoff CE; Shah DH
Bioorg Med Chem Lett; 2000 Oct; 10(20):2279-82. PubMed ID: 11055338
[TBL] [Abstract][Full Text] [Related]
17. Irreversible inhibition of serine proteases - design and in vivo activity of diaryl alpha-aminophosphonate derivatives.
Sieńczyk M; Oleksyszyn J
Curr Med Chem; 2009; 16(13):1673-87. PubMed ID: 19442139
[TBL] [Abstract][Full Text] [Related]
18. Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design.
Tully DC; Vidal A; Chatterjee AK; Williams JA; Roberts MJ; Petrassi HM; Spraggon G; Bursulaya B; Pacoma R; Shipway A; Schumacher AM; Danahay H; Harris JL
Bioorg Med Chem Lett; 2008 Nov; 18(22):5895-9. PubMed ID: 18752942
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in the design of mechanism-based and alternate substrate inhibitors of serine proteases.
Zhong J; Groutas WC
Curr Top Med Chem; 2004; 4(12):1203-16. PubMed ID: 15320721
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: design, synthesis, and biological activity.
Xue F; Seto CT
Bioorg Med Chem; 2006 Dec; 14(24):8467-87. PubMed ID: 16971130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
